Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
第一作者:
Woonyoung,Choi
第一单位:
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
作者:
主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);印迹法, 蛋白质(Blotting, Western);癌, 基底细胞(Carcinoma, Basal Cell);癌, 鳞状细胞(Carcinoma, Squamous Cell);细胞分化(Cell Differentiation);细胞增殖(Cell Proliferation);顺铂(Cisplatin);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);队列研究(Cohort Studies);多柔比星(Doxorubicin);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因表达谱(Gene Expression Profiling);人类(Humans);男(雄)性(Male);甲氨蝶呤(Methotrexate);微RNAs(MicroRNAs);肌肿瘤(Muscle Neoplasms);突变(Mutation);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤侵润(Neoplasm Invasiveness);肿瘤分期(Neoplasm Staging);PPARγ(PPAR gamma);预后(Prognosis);RNA, 信使(RNA, Messenger);受体, 成纤维细胞生长因子, 3型(Receptor, Fibroblast Growth Factor, Type 3);受体, 雌激素(Receptors, Estrogen);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);膀胱肿瘤(Urinary Bladder Neoplasms);长春碱(Vinblastine)
DOI
10.1016/j.ccr.2014.01.009
PMID
24525232
发布时间
2022-03-30
- 浏览191

Cancer cell
152-65页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文